Pin Zhang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Recombinant Human

Papillary Thyroid

Top Venues

British journal of clinical pharmacology

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Sheng Yang, Shan-Shan Chen, Chang-Gong Zhang, Ying-Lei Zhou, Meng Xiu, Pin Zhang
Low-dose pegylated recombinant human granulocyte-colony stimulating factor as hematopoietic support for adjuvant chemotherapy in Chinese patients with breast cancer: An open-label, randomized, non-inferiority trial. British journal of clinical pharmacology (2024)
Junning Cao, Hongqian Guo, Dongmei Ji, Weina Shen, Shun Zhang, Chih-Yi Hsieh, Sui Xiong Cai, Ye Edward Tian, Cong Xu, Pin Zhang, Binghe Xu
Safety, Tolerability, and Pharmacokinetics of Senaparib, a Novel PARP1/2 Inhibitor, in Chinese Patients With Advanced Solid Tumors: A Phase I Trial. The oncologist (2023)
Meng Xiu, Pin Zhang, Xiang Wang, Ying Fan, Qiao Li, Qing Li, Jiayu Wang, Lin Dong, Yang Luo, Peng Yuan, Zongbi Yi, Bing-He Xu
Survival outcomes for dose-dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple-negative breast cancer: A prospective cohort study with propensity-matched analysis. International journal of cancer 151 (4) (2022)